amlodipine has been researched along with Cardiac Output, Low in 5 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the main Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) report, we investigated outcomes in 15 245 high-risk hypertensive subjects treated with valsartan- or amlodipine-based regimens." | 2.72 | The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. ( Amerena, J; Balazovjech, I; Brunner, HR; Cassel, G; Herczeg, B; Hua, TA; Julius, S; Kjeldsen, SE; Koylan, N; Laragh, J; Magometschnigg, D; Majahalme, S; Martinez, F; McInnes, GT; Oigman, W; Schork, MA; Seabra Gomes, R; Weber, MA; Zanchetti, A; Zhu, JR, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Julius, S | 1 |
| Weber, MA | 1 |
| Kjeldsen, SE | 1 |
| McInnes, GT | 1 |
| Zanchetti, A | 1 |
| Brunner, HR | 1 |
| Laragh, J | 1 |
| Schork, MA | 1 |
| Hua, TA | 1 |
| Amerena, J | 1 |
| Balazovjech, I | 1 |
| Cassel, G | 1 |
| Herczeg, B | 1 |
| Koylan, N | 1 |
| Magometschnigg, D | 1 |
| Majahalme, S | 1 |
| Martinez, F | 1 |
| Oigman, W | 1 |
| Seabra Gomes, R | 1 |
| Zhu, JR | 1 |
| Leenen, FH | 1 |
| Nwachuku, CE | 1 |
| Black, HR | 1 |
| Cushman, WC | 1 |
| Davis, BR | 1 |
| Simpson, LM | 1 |
| Alderman, MH | 1 |
| Atlas, SA | 1 |
| Basile, JN | 1 |
| Cuyjet, AB | 1 |
| Dart, R | 1 |
| Felicetta, JV | 1 |
| Grimm, RH | 1 |
| Haywood, LJ | 1 |
| Jafri, SZ | 1 |
| Proschan, MA | 1 |
| Thadani, U | 1 |
| Whelton, PK | 1 |
| Wright, JT | 1 |
| Gabbarini, F | 1 |
| Zhang, X | 1 |
| Kichuk, MR | 1 |
| Mital, S | 1 |
| Oz, M | 1 |
| Michler, R | 1 |
| Nasjletti, A | 1 |
| Kaley, G | 1 |
| Hintze, TH | 1 |
| Cleophas, TJ | 1 |
| van der Meulen, J | 1 |
| van de Luit, L | 1 |
| Zwinderman, AH | 1 |
3 trials available for amlodipine and Cardiac Output, Low
| Article | Year |
|---|---|
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; | 2006 |
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Amlodipine; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Black People; Blood Glucose; Blood | 2006 |
Daytime-selective antihypertensive activity of celiprolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme | 1999 |
2 other studies available for amlodipine and Cardiac Output, Low
| Article | Year |
|---|---|
A 61-year-old man with Holmes' heart.
Topics: Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiac Output, Low; Heart Defects, Con | 1999 |
Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Bradykinin Receptor Antagonists; C | 1999 |